Zai Lab Limited (HKG:9688)
17.10
-0.18 (-1.04%)
Apr 29, 2026, 4:08 PM HKT
Zai Lab Employees
Zai Lab had 1,784 employees as of December 31, 2025. The number of employees decreased by 85 or -4.55% compared to the previous year.
Employees
1,784
Change (1Y)
-85
Growth (1Y)
-4.55%
Revenue / Employee
2.01M HKD
Profits / Employee
-765.85K HKD
Market Cap
19.49B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Ascletis Pharma | 208 |
| Keymed Biosciences | 1,625 |
| Ascentage Pharma Group International | 767 |
| CStone Pharmaceuticals | 136 |
| Duality Biotherapeutics | 231 |
| InnoCare Pharma | 1,176 |
| CARsgen Therapeutics Holdings | 355 |
| Genscript Biotech | 6,165 |
Zai Lab News
- 6 days ago - Zai Lab to Announce First Quarter 2026 Financial Results and Recent Corporate Updates on May 7, 2026 - Business Wire
- 8 days ago - Zai Lab Transcript: Study update - Transcripts
- 9 days ago - ZLAB: Zai Lab Unveils Promising Data for ZL-1503 in Treating Atopic Diseases - GuruFocus
- 10 days ago - Zai Lab Presents New Preclinical Data Suggesting ZL-1503, an IL-13/IL-31Rα Bispecific Antibody, Provides Rapid Itch Relief and Reduction in Inflammation in Atopic Diseases - Business Wire
- 11 days ago - ZLAB: Zai Lab Showcases Promising Clinical Data for Cancer Treatment - GuruFocus
- 11 days ago - Zai Lab Presents New Data Demonstrating Zocilurtatug Pelitecan (Zoci) Induces Rapid and Robust Intracranial Responses in Small Cell Lung Cancer with Brain Metastases and Promising Activity in Other Neuroendocrine Carcinomas - Business Wire
- 13 days ago - Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas - GlobeNewsWire
- 27 days ago - Zai Lab Stock Gains 8% Over Clinical Trial Collaboration With Amgen - Nasdaq